- Home
- / Arbor Biotechnologies
Arbor Biotechnologies
Total Funding
$215 M
Arbor Biotechnologies Summary
Company Summary
- Overview
- Arbor Biotechnologies is a company that provides genetic medicines through the discovery of programmable DNA editors. It develops genomic tools that use AI, machine learning, and screening to discover and manage novel gene-editing systems.
- Type
- Private
- Status
- Active
- Founded
- 2016
- HQ
- Cambridge, MA, US | view all locations
- Website
- https://arbor.bio
- Cybersecurity rating
Table of Contents
Key People
Pam Stetkiewicz, Chief Operating Officer
Ajim Tamboli, Chief Financial Officer
David Cheng, Chief Technology Officer
LocationsView all
1 location detected
Cambridge, MA HQ
United States
20 Acorn Park Drive, Suite 500